14h
Medical Device Network on MSNPeijia Medical partners with dsm-firmenich on polymer heart valve materialsThe parties have united for the R&D of ultra-high molecular weight polyethylene and thermoplastic polyurethane heart valve ...
Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.
Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...
Co., Ltd. held a strategic innovation cooperation signing ceremony and a press conference to announce the research and ...
13d
Medical Device Network on MSNCardiac Dimensions snags $53m for mitral valve deviceCardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...
MiRus announced that it launched a U.S. multi-center early feasibility study for its Siegel transcatheter heart valve (THV).
Over 100 patients successfully treated with the DurAVR ® THV, including de novo (first time) aortic stenosis cases, valve-in-valve (ViV) patients and complex anatomies such as bicuspid aortic valve ...
When this happens, the heart has to work harder to pump blood ... is used to place one or more tiny clips on the tricuspid valve leaflets to prevent blood from leaking back into the right atrium.
What Happens During Minimally Invasive Heart Valve Surgery? Minimally invasive heart valve surgery is a type of surgery performed through smaller incisions. This type of surgery reduces blood loss ...
MiRus is pleased to announce the launch of the US multi-center Early Feasibility Study of the Siegel™ 8-Fr aortic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results